Image Description (1)
Glatiramer Acetate Injection, Solution
Product Images NDC 0832-6085
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 0832-6085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (10)
Image Description (11)
Image Description (12)
Image Description (2)
Image Description (20mgcarton)
This text provides information about Glatiramer Acetate Injection, a medication used for subcutaneous injection once daily. It includes details on dosage, storage conditions, and the contents of each pre-filled syringe. Additionally, it mentions the manufacturer, Upsher-Smith Laboratories, LLC.*
Image Description (3)
This text provides instructions on areas to avoid for certain types of medical or cosmetic treatments. It mentions avoiding specific regions of the abdomen, back, hips, arms, and thighs. The description encourages avoiding fleshy areas around the belly button, upper hip, upper back, arms, and upper back portion 2 inches above the knee and 2 inches below the groin. These guidelines are likely aimed at ensuring safety and effectiveness during treatments like injections or procedures targeting these areas.*
Image Description (4)
Image Description (40mgcarton)
This is information related to a medication called Glatiramer Acetate Injection, which is administered three times a week via subcutaneous injection. Each pre-filled syringe contains 40 mg of glatiramer acetate solution. The medication guide should be provided to each patient by the pharmacist. It is important to store the syringes refrigerated at 36° to 46°F (2° 0 8°C) and protect them from light. The medication is distributed by Upsher-Smith Laboratories, LLC.*
Image Description (5)
Image Description (6)
Image Description (7)
Image Description (8)
Image Description (9)
Image Description (A)
This is a statistical data related to the second exacerbation rate (%), showing a significant result with a p-value of 0.0005 and a Hazard Ratio of 0.55. The data seems to compare the effectiveness of a placebo versus Glatiramer Acetate Injection over a period of time from Day 900 to Day 000.*
Image Description (B)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
